RxDoctor Payments Data

Janel Whidbee

Psychiatry · San Antonio, TXNPI 1518047752

Payments from drug & device makers

$6,567in general payments, 2019–2025

Across 370 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$1K
  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$959
  • Otsuka America Pharmaceutical, Inc.$730
  • Teva Pharmaceuticals USA, Inc.$401
  • Neurocrine Biosciences, Inc.$388
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$6,43698%
  • Education$1302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,567 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine12$95,526
TrintellixVortioxetine Hydrobromide86$58,355
RexultiBrexpiprazole14$20,083
Bupropion XlBupropion Hcl163$6,731
Desvenlafaxine Succinate ErDesvenlafaxine Succinate82$4,758
Lisdexamfetamine Dimesylate13$2,622
Clozapine12$1,217
Duloxetine Hcl78$973
Armodafinil15$814
Lamotrigine51$655
Clonazepam107$614
Vilazodone Hcl11$576
Olanzapine14$541
Venlafaxine Hcl ErVenlafaxine Hcl21$501
Aripiprazole18$498

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$401$95,52612 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$959$58,35586 claims
Otsuka America Pharmaceutical, Inc.Rexulti$730$20,08314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →